Dagalea, Ruel L.
HRN: 17-95-75 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/03/2022
MUPIROCIN 2%, 15G (TUBE)
11/03/2022
11/10/2022
TOPICAL
Thin Application
BID
Soft Tissue Injuries
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes